LYON, France, Dec 18, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that it has filed a 510(k) marketing application with the U.S. Food and Drug Administration (FDA) for its newly designed, high-end Sonolith I-Sys
LYON, France, Nov 26, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it showcased the Ablatherm-HIFU technology and next generation Sonolith I-Sys device at the French Association of Urology (AFU) Annual
Third Quarter 2008 Highlights:, Nov 20, 2008 (GlobeNewswire via COMTEX News Network) -- * Cash position of EUR 14.1 million (USD 19.8 million) supporting growth initiatives * Total HIFU revenue of EUR 1.9 million (USD 2.8 million), up 16.7% sequentially * Gross profit of EUR 2.0 million (USD 2.9
LYON, France, Oct 30, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2008 earnings announcement, which will take place on Thursday, November 20, 2008, before the opening of
LYON, France, Oct 3, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its Ablatherm-HIFU and next generation Sonolith I-Sys devices were highlighted at two major European urological conferences: the 60th
LYON, France, Sep 25, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its High Intensity Focused Ultrasound (HIFU) technology was highlighted at the City of Hope Second Annual Conference on New Technologies